WELLS FARGO & COMPANY/MN
Position in BCLI — Brainstorm Cell Therapeutics Inc.
CIK 72971
SAN FRANCISCO, CA
Position in BCLI
as of Jun 30, 2025
· filed Aug 14, 2025
Position Value
$1,497
-$188 QoQ
Shares Held
1,338
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BCLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,878 across 417 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in BCLI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-06-30 | $1,497 | 1,338 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,685 | 1,338 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,036 | 1,338 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,138 | 52,777 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,795 | 28,811 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $16,300 | 29,110 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $8,066 | 29,882 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $8,075 | 40,377 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $76,948 | 37,354 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $81,866 | 24,808 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $32,588 | 19,871 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $90,092 | 20,383 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $49,395 | 17,897 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $54,515 | 16,225 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $74,232 | 18,558 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $43,500 | 13,182 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $48,662 | 12,806 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $117,074 | 30,568 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $465,093 | 102,670 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,141,947 | 67,491 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $665,110 | 59,332 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $72,397 | 15,603 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||